Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis
Clinical trial NCT02043548 · COMPLETED
Trial details
- NCT number
- NCT02043548
- Sponsor
- Chester Oddis
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2019-07-30
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.